Nu Skin Enterprises, Inc. (NUS) is likely to register a decline in the top and the bottom line when it reports first-quarter 2024 earnings on May 8. The Zacks Consensus Estimate for revenues is pegged at $430.6 million, suggesting a fall of 10.6% from the prior-year quarter’s reported figure. The Zacks Consensus Estimate for quarterly earnings has remained unchanged in the past 30 days at 5 cents per share. The projection indicates a decline of 86.5% from the figure reported in the year-ago period quarter. ...